Epithalon Research: Telomerase, Pineal Regulation & the Khavinson Studies
A study-by-study look at Epithalon (AEDG) — telomerase activity in cell culture, melatonin rhythm effects and the Russian longevity cohorts.
Mechanism of action
Epithalon (Epitalon) is a synthetic tetrapeptide, Ala-Glu-Asp-Gly (AEDG), derived from Epithalamin — a peptide extract characterised by Vladimir Khavinson's group in St Petersburg.
The proposed mechanism is epigenetic rather than receptor-mediated: the short peptide is small enough to enter the nucleus, and cell-culture work reports binding to specific promoter regions and induction of telomerase reverse transcriptase (hTERT) expression, with corresponding telomere elongation in somatic cell lines.
A second strand of research concerns pineal function — restoration of age-disrupted melatonin secretion rhythms and downstream effects on cortisol and gonadotropin cycling in aged animal models.
The Epithalon literature is dominated by the Khavinson group and by Russian-language journals. That origin is a feature of the dataset, not a flaw; readers can evaluate the findings against the study designs described below.
The studies
The studies below are the ones most often cited in the Epithalon literature. Each card notes the design and the population tested.
Telomerase induction and telomere elongation in human somatic cells
To determine whether the AEDG tetrapeptide induces telomerase activity and telomere elongation in human fetal fibroblast cultures.
Human somatic cell culture · telomerase activity assay and telomere length measurement
- Induced
- Telomerase activity
- Increased
- Telomere length
- Observed
- Additional population doublings
vs untreated controls
reported by 33%
beyond the Hayflick limit in treated cultures
- This is the foundational citation behind Epithalon's reputation as a telomerase peptide.
- The result is a cell-culture finding. It does not establish telomere effects in a living organism, and independent replication remains limited.
- Telomerase induction is a double-edged mechanism — the same pathway is implicated in tumour cell immortality, which is why the safety literature here matters as much as the efficacy literature.
Pineal peptide regulation of melatonin and neuroendocrine rhythm
To assess whether pineal peptide preparations restore age-disrupted circadian melatonin secretion and associated neuroendocrine rhythms.
Aged rodent models and small elderly human cohorts · melatonin, cortisol and gonadotropin profiling
- Increased
- Nocturnal melatonin
- Partially restored
- Circadian rhythm amplitude
- Small
- Cohort sizes
in aged subjects
limits generalisability
- The melatonin-rhythm work is the most mechanistically coherent part of the Epithalon literature.
- Effects were most pronounced in aged subjects with already-flattened rhythms, not in young healthy ones.
- Cohorts were small and largely unblinded; these are directional findings, not outcome-trial evidence.
Long-term follow-up of elderly cohorts treated with pineal peptide preparations
To follow mortality and age-related morbidity in elderly patients given repeated courses of Epithalamin/Epithalon compared with untreated controls over several years.
Elderly cohorts followed for 6-12 years · non-randomised, single-group comparisons
- Reported
- Reported mortality reduction
- Absent
- Randomisation
- None to date
- Independent replication
in treated cohorts
- These cohort reports are the source of Epithalon's life-extension reputation. They are observational and not randomised or independently replicated.
- Without randomisation or blinding, selection effects cannot be excluded.
- Treat this work as historical context for why Epithalon is studied, rather than as demonstrated human benefit.
Storage & handling
Epithalon research material is supplied as a lyophilised powder. Store sealed vials frozen or refrigerated, away from light and moisture.
Reconstitute with bacteriostatic water added slowly down the inner wall of the vial; swirl gently rather than shaking, as short peptides are sensitive to mechanical stress.
Keep reconstituted solution at 2-8 °C and use within the window set by your lab's standard operating procedures. Avoid repeated freeze-thaw cycles.
All information on this page is provided for laboratory and educational reference only. Peptides Lab SA (PTY) Ltd supplies compounds strictly for in-vitro research use. Nothing here is medical advice, a dosing recommendation, or a claim of human safety or efficacy.